MedTrace Logo

Safety, Tolerability and Pharmacokinetics of BIBW 2948 BS for HandiHaler® in Healthy Male Volunteers

NCT02216461 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2014-08-15

No results posted yet for this study

Summary

To investigate safety, tolerability, and pharmacokinetics of BIBW 2948 BS after repeated dosing

Conditions

  • Healthy

Interventions

DRUG

Low dose of BIBW 2948 BS for oral inhalation

DRUG

Medium dose of BIBW 2948 BS for oral inhalation

DRUG

High dose of BIBW 2948 BS for oral inhalation

DRUG

Placebo

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2006-04-30

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02216461 on ClinicalTrials.gov